Bioxyne Ltd Market Cap ($120.96 Million)
Market Cap & Net Worth: Bioxyne Ltd (BXN)
Bioxyne Ltd market cap. Bioxyne Ltd (AU:BXN) has a market capitalization of $120.96 Million (AU$170.95 Million) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #18256 globally and #557 in its home market, demonstrating a 21.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioxyne Ltd's stock price AU$1.10 by its total outstanding shares 2239909288 (2.24 Billion). Also see Bioxyne Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Bioxyne Ltd Market Cap History (2015–2026)
Bioxyne Ltd market cap history from 2015 to 2026. Data shows growth from $24.41 Million to $1.74 Billion (54.24% CAGR). Check BXN share price today for real-time trading data and today's change.
Bioxyne Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioxyne Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore BXN net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.19x
Bioxyne Ltd's market cap is 2.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.58x
Bioxyne Ltd's market cap is 13.58 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $22.19 Million | $2.02 Million | $223.85K | 10.96x | 99.12x |
| 2017 | $145.81 Million | $2.05 Million | -$765.75K | 70.98x | N/A |
| 2018 | $52.30 Million | $2.15 Million | -$1.31 Million | 24.31x | N/A |
| 2019 | $22.19 Million | $2.20 Million | -$1.27 Million | 10.08x | N/A |
| 2020 | $19.02 Million | $2.26 Million | -$593.10K | 8.42x | N/A |
| 2021 | $45.96 Million | $2.11 Million | -$495.73K | 21.78x | N/A |
| 2022 | $38.04 Million | $463.64K | -$494.02K | 82.04x | N/A |
| 2023 | $17.43 Million | $5.16 Million | -$1.94 Million | 3.38x | N/A |
| 2024 | $42.79 Million | $9.33 Million | -$13.33 Million | 4.59x | N/A |
| 2025 | $66.56 Million | $30.42 Million | $4.90 Million | 2.19x | 13.58x |
Competitor Companies of BXN by Market Capitalization
Companies near Bioxyne Ltd in the global market cap rankings as of November 7, 2026. Also see balance sheet size of Bioxyne Ltd for a full breakdown of the balance sheet.
Key companies related to Bioxyne Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #101 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #527 globally with a market cap of $51.26 Billion USD ( €43.85 Billion EUR).
- Danone SA (F:BSND): Ranked #668 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €94.80 |
| #101 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF87.23 |
| #527 | Danone SA | PA:BN | $51.26 Billion | €68.56 |
| #668 | Danone SA | F:BSND | $39.61 Billion | €13.30 |
Market Capitalization of Bioxyne Ltd (2015–2026)
Market capitalization of Bioxyne Ltd from 2015 to today. Between 2015 and today, Bioxyne Ltd's market cap moved from $24.41 Million to $ 1.74 Billion, with a yearly change of 54.24%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$1.74 Billion | +2519.05% |
| 2025 | AU$66.56 Million | +55.56% |
| 2024 | AU$42.79 Million | +145.45% |
| 2023 | AU$17.43 Million | -54.17% |
| 2022 | AU$38.04 Million | -17.24% |
| 2021 | AU$45.96 Million | +141.67% |
| 2020 | AU$19.02 Million | -14.29% |
| 2019 | AU$22.19 Million | -57.58% |
| 2018 | AU$52.30 Million | -64.13% |
| 2017 | AU$145.81 Million | +557.14% |
| 2016 | AU$22.19 Million | -9.09% |
| 2015 | AU$24.41 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Bioxyne Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $120.96 Million USD |
| MoneyControl | $120.96 Million USD |
| MarketWatch | $120.96 Million USD |
| marketcap.company | $120.96 Million USD |
| Reuters | $120.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bioxyne Ltd
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Onlin… Read more